Fluocinonide


Thông tin thuốc gốc
Chỉ định và Liều dùng
Topical/Cutaneous
Corticosteroid-responsive dermatoses
Adult: As 0.05% cream/gel/solution/ointment: Apply thinly onto affected area(s) 2-4 times daily depending on the severity of the condition. Reduce dosage once the condition improves. As 0.1% cream: Apply thinly onto affected area(s) once or twice daily. Discontinue when control is achieved; re-evaluate treatment if condition does not improve within 2 weeks.
Child: As 0.05% cream/gel/solution/ointment: >1 year Use the minimum effective dose and limit treatment to 5 days without occlusion. As 0.1% cream: ≥12 years Same as adult dose.
Chống chỉ định
Untreated fungal, tuberculous, viral, or bacterial skin infections; acne, rosacea, perioral dermatitis, anogenital pruritus.
Thận trọng
Patient with psoriasis. Children. Pregnancy and lactation. Avoid contact with eyes and prolonged facial application.
Tác dụng không mong muốn
Significant: Hypercortisolism or suppression of hypothalamic-pituitary-adrenal (HPA) axis (especially in children); Kaposi’s sarcoma (prolonged use); allergic contact dermatitis, local application site effects (e.g. skin atrophy, irritation, burning, itching, dryness, telangiectasia, striae, miliaria, perioral dermatitis, folliculitis, acneiform eruptions, hypopigmentation), skin infections; systemic effects (e.g Cushing’s syndrome, hyperglycaemia, glycosuria); growth retardation (prolonged use in children). Rarely, central serous chorioretinopathy.
Skin and subcutaneous tissue disorders: Hypertrichosis, erythema, swelling, pain at application site; skin exfoliation and tightness.
Chỉ số theo dõi
Monitor HPA axis suppression (e.g. ACTH stimulation test, urine free cortisol test); signs of bacterial or fungal infection. Routinely check growth in children (prolonged use).
Tương tác
May diminish the antineoplastic effect of aldesleukin.
Tác dụng
Description:
Mechanism of Action: Fluocinonide is a highly potent fluorinated corticosteroid which has anti-inflammatory, antipruritic, and vasoconstrictive effects. It depresses the formation, release, and action of endogenous chemical mediators of inflammation (e.g. kinins, histamine, liposomal enzymes, prostaglandins) via the induction of phospholipase A2 inhibitory proteins (lipocortins) and sequential inhibition of arachidonic acid release.
Pharmacokinetics:
Absorption: Absorbed percutaneously.
Metabolism: Metabolised mainly in the liver.
Excretion: Via urine and bile.
Đặc tính

Chemical Structure Image
Fluocinonide

Source: National Center for Biotechnology Information. PubChem Compound Summary for CID 9642, Fluocinonide. https://pubchem.ncbi.nlm.nih.gov/compound/Fluocinonide. Accessed Oct. 27, 2020.

Bảo quản
Store between 15-30°C. Protect from excessive heat exposure.
Phân loại MIMS
Corticoid dùng tại chỗ
Phân loại ATC
D07AC08 - fluocinonide ; Belongs to the class of potent (group III) corticosteroids. Used in the treatment of dermatological diseases.
Tài liệu tham khảo
Anon. Fluocinonide. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 05/10/2020.

Buckingham R (ed). Fluocinonide. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 05/10/2020.

Fluocinonide Cream, Gel, Ointment 0.5% (Taro Pharmaceuticals U.S.A., Inc.). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 23/10/2020.

Fluocinonide Gel 0.05% (Cosette Pharmaceuticals, Inc.). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 05/10/2020.

Fluocinonide Topical Solution 0.05% (Rising Pharmaceuticals, Inc.). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 05/10/2020.

Joint Formulary Committee. Fluocinonide. British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 05/10/2020.

Lidex 0.05% Ointment (Euro-Med Laboratories Phil., Inc.). MIMS Philippines. http://www.mims.com/philippines. Accessed 23/10/2020.

Metosyn FAPG Cream 0.05% (Reig Jofre UK Limited). MHRA. https://products.mhra.gov.uk/. Accessed 05/10/2020.

Metosyn Ointment 0.05% (Reig Jofre UK Limited). MHRA. https://products.mhra.gov.uk/. Accessed 05/10/2020.

Vanos Cream 0.1% (Valeant Pharmaceuticals North America LLC). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 05/10/2020.

Thông báo miễn trừ trách nhiệm: Thông tin này được MIMS biên soạn một cách độc lập dựa trên thông tin của Fluocinonide từ nhiều nguồn tài liệu tham khảo và được cung cấp chỉ cho mục đích tham khảo. Việc sử dụng điều trị và thông tin kê toa có thể khác nhau giữa các quốc gia. Vui lòng tham khảo thông tin sản phẩm trong MIMS để biết thông tin kê toa cụ thể đã qua phê duyệt ở quốc gia đó. Mặc dù đã rất nỗ lực để đảm bảo nội dung được chính xác nhưng MIMS sẽ không chịu trách nhiệm hoặc nghĩa vụ pháp lý cho bất kỳ yêu cầu bồi thường hay thiệt hại nào phát sinh do việc sử dụng hoặc sử dụng sai các thông tin ở đây, về nội dung thông tin hoặc về sự thiếu sót thông tin, hoặc về thông tin khác. © 2024 MIMS. Bản quyền thuộc về MIMS. Phát triển bởi MIMS.com
  • Flunide
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in